Bellus Health, 6% 15nov2026, USD (Conv.) (FIGI BBG0000FHDT7)
国際債券, 転換社債, Senior Unsecured
国際債券, 転換社債, Senior Unsecured
|
BELLUS Health Inc. operates as a clinical-stage biopharmaceutical company. The Company develops drugs for rare diseases, including conditions that affect the kidneys, as well as treatments for sarcoidosis and hemolytic uremic syndrome.
|
|
|
|
|
|
|
|
|
最も包括的なデータベースを探索
1 000 000
債券
80 234
株
167 970
ETF&投資信託
70 000
インデックス
最も効率的な方法でポートフォリオを追跡